Microvascular and Macrovascular Disease and Risk for Major Peripheral Arterial Disease in Patients With Type 2 Diabetes.
Identifieur interne : 001B17 ( Main/Exploration ); précédent : 001B16; suivant : 001B18Microvascular and Macrovascular Disease and Risk for Major Peripheral Arterial Disease in Patients With Type 2 Diabetes.
Auteurs : Kamel Mohammedi [Australie] ; Mark Woodward [États-Unis] ; Yoichiro Hirakawa [Australie] ; Sophia Zoungas [Australie] ; Bryan Williams [Royaume-Uni] ; Liu Lisheng [République populaire de Chine] ; Anthony Rodgers [Australie] ; Giuseppe Mancia [Italie] ; Bruce Neal [Australie] ; Stephen Harrap [Australie] ; Michel Marre [France] ; John Chalmers [Australie]Source :
- Diabetes care [ 1935-5548 ] ; 2016.
Descripteurs français
- KwdFr :
- Adulte d'âge moyen, Association médicamenteuse, Diabète de type 2 (), Diabète de type 2 (traitement médicamenteux), Détermination du point final, Facteurs de risque, Femelle, Gliclazide (administration et posologie), Glycémie (métabolisme), Humains, Hémoglobine A glycosylée (métabolisme), Indapamide (administration et posologie), Maladie artérielle périphérique (), Modèles de hasards proportionnels, Mâle, Périndopril (administration et posologie), Sujet âgé, Études de suivi.
- MESH :
- administration et posologie : Gliclazide, Indapamide, Périndopril.
- métabolisme : Glycémie, Hémoglobine A glycosylée.
- traitement médicamenteux : Diabète de type 2.
- Adulte d'âge moyen, Association médicamenteuse, Diabète de type 2, Détermination du point final, Facteurs de risque, Femelle, Humains, Maladie artérielle périphérique, Modèles de hasards proportionnels, Mâle, Sujet âgé, Études de suivi.
English descriptors
- KwdEn :
- Aged, Blood Glucose (metabolism), Diabetes Mellitus, Type 2 (complications), Diabetes Mellitus, Type 2 (drug therapy), Drug Combinations, Endpoint Determination, Female, Follow-Up Studies, Gliclazide (administration & dosage), Hemoglobin A, Glycosylated (metabolism), Humans, Indapamide (administration & dosage), Male, Middle Aged, Perindopril (administration & dosage), Peripheral Arterial Disease (complications), Proportional Hazards Models, Risk Factors.
- MESH :
- chemical , administration & dosage : Gliclazide, Indapamide, Perindopril.
- chemical , metabolism : Blood Glucose, Hemoglobin A, Glycosylated.
- complications : Diabetes Mellitus, Type 2, Peripheral Arterial Disease.
- drug therapy : Diabetes Mellitus, Type 2.
- Aged, Drug Combinations, Endpoint Determination, Female, Follow-Up Studies, Humans, Male, Middle Aged, Proportional Hazards Models, Risk Factors.
Abstract
Peripheral arterial disease (PAD) is a common manifestation of atherosclerosis in type 2 diabetes, but the relationship between other vascular diseases and PAD has been poorly investigated. We examined the impact of previous microvascular and macrovascular disease on the risk of major PAD in patients with type 2 diabetes.
DOI: 10.2337/dc16-0588
PubMed: 27456835
Affiliations:
- Australie, France, Italie, Royaume-Uni, République populaire de Chine, États-Unis
- Angleterre, Grand Londres, Lombardie, Maryland, Nouvelle-Galles du Sud, Île-de-France
- Londres, Milan, Paris, Pékin, Sydney
- University College de Londres, Université de Sydney
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 001832
- to stream PubMed, to step Curation: 001809
- to stream PubMed, to step Checkpoint: 001809
- to stream Ncbi, to step Merge: 003898
- to stream Ncbi, to step Curation: 003898
- to stream Ncbi, to step Checkpoint: 003898
- to stream Main, to step Merge: 001B13
- to stream Main, to step Curation: 001B17
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Microvascular and Macrovascular Disease and Risk for Major Peripheral Arterial Disease in Patients With Type 2 Diabetes.</title><author><name sortKey="Mohammedi, Kamel" sort="Mohammedi, Kamel" uniqKey="Mohammedi K" first="Kamel" last="Mohammedi">Kamel Mohammedi</name><affiliation wicri:level="4"><nlm:affiliation>The George Institute for Global Health, University of Sydney, Sydney, New South Wales, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>The George Institute for Global Health, University of Sydney, Sydney, New South Wales</wicri:regionArea><orgName type="university">Université de Sydney</orgName><placeName><settlement type="city">Sydney</settlement><region type="état">Nouvelle-Galles du Sud</region></placeName></affiliation></author><author><name sortKey="Woodward, Mark" sort="Woodward, Mark" uniqKey="Woodward M" first="Mark" last="Woodward">Mark Woodward</name><affiliation wicri:level="2"><nlm:affiliation>The George Institute for Global Health, University of Sydney, Sydney, New South Wales, Australia The George Institute for Global Health, University of Oxford, Oxford, U.K. Department of Epidemiology, Johns Hopkins University, Baltimore, MD.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Maryland</region></placeName><wicri:cityArea>The George Institute for Global Health, University of Sydney, Sydney, New South Wales, Australia The George Institute for Global Health, University of Oxford, Oxford, U.K. Department of Epidemiology, Johns Hopkins University, Baltimore</wicri:cityArea></affiliation></author><author><name sortKey="Hirakawa, Yoichiro" sort="Hirakawa, Yoichiro" uniqKey="Hirakawa Y" first="Yoichiro" last="Hirakawa">Yoichiro Hirakawa</name><affiliation wicri:level="4"><nlm:affiliation>The George Institute for Global Health, University of Sydney, Sydney, New South Wales, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>The George Institute for Global Health, University of Sydney, Sydney, New South Wales</wicri:regionArea><orgName type="university">Université de Sydney</orgName><placeName><settlement type="city">Sydney</settlement><region type="état">Nouvelle-Galles du Sud</region></placeName></affiliation></author><author><name sortKey="Zoungas, Sophia" sort="Zoungas, Sophia" uniqKey="Zoungas S" first="Sophia" last="Zoungas">Sophia Zoungas</name><affiliation wicri:level="4"><nlm:affiliation>The George Institute for Global Health, University of Sydney, Sydney, New South Wales, Australia Monash Centre for Health Research and Implementation, School of Public Health and Preventive Medicine, Monash University, Clayton, Victoria, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>The George Institute for Global Health, University of Sydney, Sydney, New South Wales, Australia Monash Centre for Health Research and Implementation, School of Public Health and Preventive Medicine, Monash University, Clayton, Victoria</wicri:regionArea><orgName type="university">Université de Sydney</orgName><placeName><settlement type="city">Sydney</settlement><region type="état">Nouvelle-Galles du Sud</region></placeName></affiliation></author><author><name sortKey="Williams, Bryan" sort="Williams, Bryan" uniqKey="Williams B" first="Bryan" last="Williams">Bryan Williams</name><affiliation wicri:level="4"><nlm:affiliation>Institute of Cardiovascular Sciences, University College London (UCL) and National Institute of Health Research UCL Hospitals Biomedical Research Centre, London, U.K.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Institute of Cardiovascular Sciences, University College London (UCL) and National Institute of Health Research UCL Hospitals Biomedical Research Centre, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region><settlement type="city">Londres</settlement></placeName><orgName type="university">University College de Londres</orgName></affiliation></author><author><name sortKey="Lisheng, Liu" sort="Lisheng, Liu" uniqKey="Lisheng L" first="Liu" last="Lisheng">Liu Lisheng</name><affiliation wicri:level="3"><nlm:affiliation>The Chinese Hypertension League Institute, Beijing, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>The Chinese Hypertension League Institute, Beijing</wicri:regionArea><placeName><settlement type="city">Pékin</settlement></placeName></affiliation></author><author><name sortKey="Rodgers, Anthony" sort="Rodgers, Anthony" uniqKey="Rodgers A" first="Anthony" last="Rodgers">Anthony Rodgers</name><affiliation wicri:level="4"><nlm:affiliation>The George Institute for Global Health, University of Sydney, Sydney, New South Wales, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>The George Institute for Global Health, University of Sydney, Sydney, New South Wales</wicri:regionArea><orgName type="university">Université de Sydney</orgName><placeName><settlement type="city">Sydney</settlement><region type="état">Nouvelle-Galles du Sud</region></placeName></affiliation></author><author><name sortKey="Mancia, Giuseppe" sort="Mancia, Giuseppe" uniqKey="Mancia G" first="Giuseppe" last="Mancia">Giuseppe Mancia</name><affiliation wicri:level="3"><nlm:affiliation>The University of Milan-Bicocca and Istituto Auxologico Italiano, Milan, Italy.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>The University of Milan-Bicocca and Istituto Auxologico Italiano, Milan</wicri:regionArea><placeName><settlement type="city">Milan</settlement><region nuts="2">Lombardie</region></placeName></affiliation></author><author><name sortKey="Neal, Bruce" sort="Neal, Bruce" uniqKey="Neal B" first="Bruce" last="Neal">Bruce Neal</name><affiliation wicri:level="4"><nlm:affiliation>The George Institute for Global Health, University of Sydney, Sydney, New South Wales, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>The George Institute for Global Health, University of Sydney, Sydney, New South Wales</wicri:regionArea><orgName type="university">Université de Sydney</orgName><placeName><settlement type="city">Sydney</settlement><region type="état">Nouvelle-Galles du Sud</region></placeName></affiliation></author><author><name sortKey="Harrap, Stephen" sort="Harrap, Stephen" uniqKey="Harrap S" first="Stephen" last="Harrap">Stephen Harrap</name><affiliation wicri:level="1"><nlm:affiliation>The University of Melbourne and Royal Melbourne Hospital, Melbourne, Victoria, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>The University of Melbourne and Royal Melbourne Hospital, Melbourne, Victoria</wicri:regionArea><wicri:noRegion>Victoria</wicri:noRegion></affiliation></author><author><name sortKey="Marre, Michel" sort="Marre, Michel" uniqKey="Marre M" first="Michel" last="Marre">Michel Marre</name><affiliation wicri:level="3"><nlm:affiliation>INSERM, UMRS 1138, Centre de Recherche des Cordeliers, Paris, France Assistance Publique Hôpitaux de Paris, Bichat Hospital, DHU FIRE, Department of Diabetology, Endocrinology and Nutrition, Paris, France Université Paris Diderot, Sorbonne Paris Cité, UFR de Médecine, Paris, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>INSERM, UMRS 1138, Centre de Recherche des Cordeliers, Paris, France Assistance Publique Hôpitaux de Paris, Bichat Hospital, DHU FIRE, Department of Diabetology, Endocrinology and Nutrition, Paris, France Université Paris Diderot, Sorbonne Paris Cité, UFR de Médecine, Paris</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author><author><name sortKey="Chalmers, John" sort="Chalmers, John" uniqKey="Chalmers J" first="John" last="Chalmers">John Chalmers</name><affiliation wicri:level="4"><nlm:affiliation>The George Institute for Global Health, University of Sydney, Sydney, New South Wales, Australia chalmers@georgeinstitute.org.au.</nlm:affiliation><country wicri:rule="url">Australie</country><wicri:regionArea>The George Institute for Global Health, University of Sydney, Sydney, New South Wales</wicri:regionArea><orgName type="university">Université de Sydney</orgName><placeName><settlement type="city">Sydney</settlement><region type="état">Nouvelle-Galles du Sud</region></placeName></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2016">2016</date><idno type="RBID">pubmed:27456835</idno><idno type="pmid">27456835</idno><idno type="doi">10.2337/dc16-0588</idno><idno type="wicri:Area/PubMed/Corpus">001832</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001832</idno><idno type="wicri:Area/PubMed/Curation">001809</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001809</idno><idno type="wicri:Area/PubMed/Checkpoint">001809</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001809</idno><idno type="wicri:Area/Ncbi/Merge">003898</idno><idno type="wicri:Area/Ncbi/Curation">003898</idno><idno type="wicri:Area/Ncbi/Checkpoint">003898</idno><idno type="wicri:Area/Main/Merge">001B13</idno><idno type="wicri:Area/Main/Curation">001B17</idno><idno type="wicri:Area/Main/Exploration">001B17</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Microvascular and Macrovascular Disease and Risk for Major Peripheral Arterial Disease in Patients With Type 2 Diabetes.</title><author><name sortKey="Mohammedi, Kamel" sort="Mohammedi, Kamel" uniqKey="Mohammedi K" first="Kamel" last="Mohammedi">Kamel Mohammedi</name><affiliation wicri:level="4"><nlm:affiliation>The George Institute for Global Health, University of Sydney, Sydney, New South Wales, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>The George Institute for Global Health, University of Sydney, Sydney, New South Wales</wicri:regionArea><orgName type="university">Université de Sydney</orgName><placeName><settlement type="city">Sydney</settlement><region type="état">Nouvelle-Galles du Sud</region></placeName></affiliation></author><author><name sortKey="Woodward, Mark" sort="Woodward, Mark" uniqKey="Woodward M" first="Mark" last="Woodward">Mark Woodward</name><affiliation wicri:level="2"><nlm:affiliation>The George Institute for Global Health, University of Sydney, Sydney, New South Wales, Australia The George Institute for Global Health, University of Oxford, Oxford, U.K. Department of Epidemiology, Johns Hopkins University, Baltimore, MD.</nlm:affiliation><country xml:lang="fr">États-Unis</country><placeName><region type="state">Maryland</region></placeName><wicri:cityArea>The George Institute for Global Health, University of Sydney, Sydney, New South Wales, Australia The George Institute for Global Health, University of Oxford, Oxford, U.K. Department of Epidemiology, Johns Hopkins University, Baltimore</wicri:cityArea></affiliation></author><author><name sortKey="Hirakawa, Yoichiro" sort="Hirakawa, Yoichiro" uniqKey="Hirakawa Y" first="Yoichiro" last="Hirakawa">Yoichiro Hirakawa</name><affiliation wicri:level="4"><nlm:affiliation>The George Institute for Global Health, University of Sydney, Sydney, New South Wales, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>The George Institute for Global Health, University of Sydney, Sydney, New South Wales</wicri:regionArea><orgName type="university">Université de Sydney</orgName><placeName><settlement type="city">Sydney</settlement><region type="état">Nouvelle-Galles du Sud</region></placeName></affiliation></author><author><name sortKey="Zoungas, Sophia" sort="Zoungas, Sophia" uniqKey="Zoungas S" first="Sophia" last="Zoungas">Sophia Zoungas</name><affiliation wicri:level="4"><nlm:affiliation>The George Institute for Global Health, University of Sydney, Sydney, New South Wales, Australia Monash Centre for Health Research and Implementation, School of Public Health and Preventive Medicine, Monash University, Clayton, Victoria, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>The George Institute for Global Health, University of Sydney, Sydney, New South Wales, Australia Monash Centre for Health Research and Implementation, School of Public Health and Preventive Medicine, Monash University, Clayton, Victoria</wicri:regionArea><orgName type="university">Université de Sydney</orgName><placeName><settlement type="city">Sydney</settlement><region type="état">Nouvelle-Galles du Sud</region></placeName></affiliation></author><author><name sortKey="Williams, Bryan" sort="Williams, Bryan" uniqKey="Williams B" first="Bryan" last="Williams">Bryan Williams</name><affiliation wicri:level="4"><nlm:affiliation>Institute of Cardiovascular Sciences, University College London (UCL) and National Institute of Health Research UCL Hospitals Biomedical Research Centre, London, U.K.</nlm:affiliation><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Institute of Cardiovascular Sciences, University College London (UCL) and National Institute of Health Research UCL Hospitals Biomedical Research Centre, London</wicri:regionArea><placeName><settlement type="city">Londres</settlement><region type="country">Angleterre</region><region type="région" nuts="1">Grand Londres</region><settlement type="city">Londres</settlement></placeName><orgName type="university">University College de Londres</orgName></affiliation></author><author><name sortKey="Lisheng, Liu" sort="Lisheng, Liu" uniqKey="Lisheng L" first="Liu" last="Lisheng">Liu Lisheng</name><affiliation wicri:level="3"><nlm:affiliation>The Chinese Hypertension League Institute, Beijing, China.</nlm:affiliation><country xml:lang="fr">République populaire de Chine</country><wicri:regionArea>The Chinese Hypertension League Institute, Beijing</wicri:regionArea><placeName><settlement type="city">Pékin</settlement></placeName></affiliation></author><author><name sortKey="Rodgers, Anthony" sort="Rodgers, Anthony" uniqKey="Rodgers A" first="Anthony" last="Rodgers">Anthony Rodgers</name><affiliation wicri:level="4"><nlm:affiliation>The George Institute for Global Health, University of Sydney, Sydney, New South Wales, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>The George Institute for Global Health, University of Sydney, Sydney, New South Wales</wicri:regionArea><orgName type="university">Université de Sydney</orgName><placeName><settlement type="city">Sydney</settlement><region type="état">Nouvelle-Galles du Sud</region></placeName></affiliation></author><author><name sortKey="Mancia, Giuseppe" sort="Mancia, Giuseppe" uniqKey="Mancia G" first="Giuseppe" last="Mancia">Giuseppe Mancia</name><affiliation wicri:level="3"><nlm:affiliation>The University of Milan-Bicocca and Istituto Auxologico Italiano, Milan, Italy.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>The University of Milan-Bicocca and Istituto Auxologico Italiano, Milan</wicri:regionArea><placeName><settlement type="city">Milan</settlement><region nuts="2">Lombardie</region></placeName></affiliation></author><author><name sortKey="Neal, Bruce" sort="Neal, Bruce" uniqKey="Neal B" first="Bruce" last="Neal">Bruce Neal</name><affiliation wicri:level="4"><nlm:affiliation>The George Institute for Global Health, University of Sydney, Sydney, New South Wales, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>The George Institute for Global Health, University of Sydney, Sydney, New South Wales</wicri:regionArea><orgName type="university">Université de Sydney</orgName><placeName><settlement type="city">Sydney</settlement><region type="état">Nouvelle-Galles du Sud</region></placeName></affiliation></author><author><name sortKey="Harrap, Stephen" sort="Harrap, Stephen" uniqKey="Harrap S" first="Stephen" last="Harrap">Stephen Harrap</name><affiliation wicri:level="1"><nlm:affiliation>The University of Melbourne and Royal Melbourne Hospital, Melbourne, Victoria, Australia.</nlm:affiliation><country xml:lang="fr">Australie</country><wicri:regionArea>The University of Melbourne and Royal Melbourne Hospital, Melbourne, Victoria</wicri:regionArea><wicri:noRegion>Victoria</wicri:noRegion></affiliation></author><author><name sortKey="Marre, Michel" sort="Marre, Michel" uniqKey="Marre M" first="Michel" last="Marre">Michel Marre</name><affiliation wicri:level="3"><nlm:affiliation>INSERM, UMRS 1138, Centre de Recherche des Cordeliers, Paris, France Assistance Publique Hôpitaux de Paris, Bichat Hospital, DHU FIRE, Department of Diabetology, Endocrinology and Nutrition, Paris, France Université Paris Diderot, Sorbonne Paris Cité, UFR de Médecine, Paris, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>INSERM, UMRS 1138, Centre de Recherche des Cordeliers, Paris, France Assistance Publique Hôpitaux de Paris, Bichat Hospital, DHU FIRE, Department of Diabetology, Endocrinology and Nutrition, Paris, France Université Paris Diderot, Sorbonne Paris Cité, UFR de Médecine, Paris</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Paris</settlement></placeName></affiliation></author><author><name sortKey="Chalmers, John" sort="Chalmers, John" uniqKey="Chalmers J" first="John" last="Chalmers">John Chalmers</name><affiliation wicri:level="4"><nlm:affiliation>The George Institute for Global Health, University of Sydney, Sydney, New South Wales, Australia chalmers@georgeinstitute.org.au.</nlm:affiliation><country wicri:rule="url">Australie</country><wicri:regionArea>The George Institute for Global Health, University of Sydney, Sydney, New South Wales</wicri:regionArea><orgName type="university">Université de Sydney</orgName><placeName><settlement type="city">Sydney</settlement><region type="état">Nouvelle-Galles du Sud</region></placeName></affiliation></author></analytic><series><title level="j">Diabetes care</title><idno type="eISSN">1935-5548</idno><imprint><date when="2016" type="published">2016</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Aged</term><term>Blood Glucose (metabolism)</term><term>Diabetes Mellitus, Type 2 (complications)</term><term>Diabetes Mellitus, Type 2 (drug therapy)</term><term>Drug Combinations</term><term>Endpoint Determination</term><term>Female</term><term>Follow-Up Studies</term><term>Gliclazide (administration & dosage)</term><term>Hemoglobin A, Glycosylated (metabolism)</term><term>Humans</term><term>Indapamide (administration & dosage)</term><term>Male</term><term>Middle Aged</term><term>Perindopril (administration & dosage)</term><term>Peripheral Arterial Disease (complications)</term><term>Proportional Hazards Models</term><term>Risk Factors</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Adulte d'âge moyen</term><term>Association médicamenteuse</term><term>Diabète de type 2 ()</term><term>Diabète de type 2 (traitement médicamenteux)</term><term>Détermination du point final</term><term>Facteurs de risque</term><term>Femelle</term><term>Gliclazide (administration et posologie)</term><term>Glycémie (métabolisme)</term><term>Humains</term><term>Hémoglobine A glycosylée (métabolisme)</term><term>Indapamide (administration et posologie)</term><term>Maladie artérielle périphérique ()</term><term>Modèles de hasards proportionnels</term><term>Mâle</term><term>Périndopril (administration et posologie)</term><term>Sujet âgé</term><term>Études de suivi</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Gliclazide</term><term>Indapamide</term><term>Perindopril</term></keywords><keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>Blood Glucose</term><term>Hemoglobin A, Glycosylated</term></keywords><keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Gliclazide</term><term>Indapamide</term><term>Périndopril</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Diabetes Mellitus, Type 2</term><term>Peripheral Arterial Disease</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Diabetes Mellitus, Type 2</term></keywords><keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr"><term>Glycémie</term><term>Hémoglobine A glycosylée</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Diabète de type 2</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Aged</term><term>Drug Combinations</term><term>Endpoint Determination</term><term>Female</term><term>Follow-Up Studies</term><term>Humans</term><term>Male</term><term>Middle Aged</term><term>Proportional Hazards Models</term><term>Risk Factors</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Adulte d'âge moyen</term><term>Association médicamenteuse</term><term>Diabète de type 2</term><term>Détermination du point final</term><term>Facteurs de risque</term><term>Femelle</term><term>Humains</term><term>Maladie artérielle périphérique</term><term>Modèles de hasards proportionnels</term><term>Mâle</term><term>Sujet âgé</term><term>Études de suivi</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Peripheral arterial disease (PAD) is a common manifestation of atherosclerosis in type 2 diabetes, but the relationship between other vascular diseases and PAD has been poorly investigated. We examined the impact of previous microvascular and macrovascular disease on the risk of major PAD in patients with type 2 diabetes.</div></front></TEI><affiliations><list><country><li>Australie</li><li>France</li><li>Italie</li><li>Royaume-Uni</li><li>République populaire de Chine</li><li>États-Unis</li></country><region><li>Angleterre</li><li>Grand Londres</li><li>Lombardie</li><li>Maryland</li><li>Nouvelle-Galles du Sud</li><li>Île-de-France</li></region><settlement><li>Londres</li><li>Milan</li><li>Paris</li><li>Pékin</li><li>Sydney</li></settlement><orgName><li>University College de Londres</li><li>Université de Sydney</li></orgName></list><tree><country name="Australie"><region name="Nouvelle-Galles du Sud"><name sortKey="Mohammedi, Kamel" sort="Mohammedi, Kamel" uniqKey="Mohammedi K" first="Kamel" last="Mohammedi">Kamel Mohammedi</name></region><name sortKey="Chalmers, John" sort="Chalmers, John" uniqKey="Chalmers J" first="John" last="Chalmers">John Chalmers</name><name sortKey="Harrap, Stephen" sort="Harrap, Stephen" uniqKey="Harrap S" first="Stephen" last="Harrap">Stephen Harrap</name><name sortKey="Hirakawa, Yoichiro" sort="Hirakawa, Yoichiro" uniqKey="Hirakawa Y" first="Yoichiro" last="Hirakawa">Yoichiro Hirakawa</name><name sortKey="Neal, Bruce" sort="Neal, Bruce" uniqKey="Neal B" first="Bruce" last="Neal">Bruce Neal</name><name sortKey="Rodgers, Anthony" sort="Rodgers, Anthony" uniqKey="Rodgers A" first="Anthony" last="Rodgers">Anthony Rodgers</name><name sortKey="Zoungas, Sophia" sort="Zoungas, Sophia" uniqKey="Zoungas S" first="Sophia" last="Zoungas">Sophia Zoungas</name></country><country name="États-Unis"><region name="Maryland"><name sortKey="Woodward, Mark" sort="Woodward, Mark" uniqKey="Woodward M" first="Mark" last="Woodward">Mark Woodward</name></region></country><country name="Royaume-Uni"><region name="Angleterre"><name sortKey="Williams, Bryan" sort="Williams, Bryan" uniqKey="Williams B" first="Bryan" last="Williams">Bryan Williams</name></region></country><country name="République populaire de Chine"><noRegion><name sortKey="Lisheng, Liu" sort="Lisheng, Liu" uniqKey="Lisheng L" first="Liu" last="Lisheng">Liu Lisheng</name></noRegion></country><country name="Italie"><region name="Lombardie"><name sortKey="Mancia, Giuseppe" sort="Mancia, Giuseppe" uniqKey="Mancia G" first="Giuseppe" last="Mancia">Giuseppe Mancia</name></region></country><country name="France"><region name="Île-de-France"><name sortKey="Marre, Michel" sort="Marre, Michel" uniqKey="Marre M" first="Michel" last="Marre">Michel Marre</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001B17 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001B17 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Asie
|area= AustralieFrV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:27456835
|texte= Microvascular and Macrovascular Disease and Risk for Major Peripheral Arterial Disease in Patients With Type 2 Diabetes.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:27456835" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a AustralieFrV1
| This area was generated with Dilib version V0.6.33. |  |